Indications
Human Menopausal Gonadotrophin is used for sterility in women who have hypo- or normogonadotropic ovarian insufficiency, where it stimulates follicle growth. It is also used for sterility in men who have hypo- or normogonadotropic hypogonadism. In men it is given in combination with HCG to stimulate spermatogenesis.
⚠️ Always consult a registered physician before taking any medicine.
Pharmacology
Human Menopausal Gonadotrophin acts directly on the ovaries and the testes, and it has both a gametotropic and a steroidogenic effect. In the ovaries, the FSH component increases the number of growing follicles and stimulates their development. FSH also raises the production of estradiol in the granulosa cells by aromatizing androgens that come from the theca cells under the influence of the LH component. In the testes, FSH brings about the change from premature to mature Sertoli cells. Mainly, it causes the seminal canals to mature and the spermatozoa to develop. However, a high concentration of androgens inside the testes is necessary for this, and it can be reached by treating with HCG beforehand.
The medicine is not effective when taken by mouth, so it is injected i.m. or s.c. Its biological effect comes mainly from its FSH and LH content. The pharmacokinetics after i.m. or s.c. injection were tested product specifically. The maximum serum level of FSH is reached 6 to 48 hours after an i.m. injection and 6 to 36 hours after an s.c. injection, respectively. After that, the serum level falls with a half-life of 56 hours (i.m.) and 51 hours (s.c.), respectively. Human Menopausal Gonadotrophin is passed out mainly through the kidneys.
Pregnancy & Breastfeeding
Human Menopausal Gonadotrophin has no indication for use during pregnancy or while a woman is breastfeeding.
⚠️ Talk to your doctor before taking any medicine during pregnancy or while breastfeeding.
Dosage Reference
⚠️ Reference ranges from official sources only. Consult your doctor for personalized dosing.